Expert Profile
An innovative, analytical and resilient team-leader with 5 years’ experience across multi-functional strategic and innovative technology consulting, business development roles and industry expertise in diverse environments working with institutional investors and decision makers. In-depth knowledge of drug development from pre-clinical research to product and portfolio management. Advanced interpersonal, communication skills combined with passion to identify and solve problems by developing strategic insights and pragmatic solutions. Strong self-driven and independent project management and negotiation ability to articulate scope-schedule-budget, delivering high-impact cost-effective sustainable solutions. Robust technical understanding and commercial knowledge coupled with ability to acquire new knowledge and skill set.
***** Consulting: Director - London (July 2009 - Present)
Delivery of Innovation and Strategy Consulting services to corporate decision makers and investors.
UMumbai - B.Sc. Microbiology and Biotechnology: 2000
UMumbai - M.Sc. Neurobiology: 2002
UCIrvine - Ph.D. Neuroscience: 2007
Cranfield School of Management - MBA Strategy and Innovation: 2010
Association of Project Management Professional - PMP
• Reviewed existing new product introduction (NPI) process, market analysis, competitor evaluation and stakeholder management. Provide recommendations to improve process to strategically align with divisional and company strategy resulting in 50% increase in NPI, 30% reduction in time to market and 9% increase in net profits.
• Provided shareholders and investors in-depth analysis, critique and recommendations on Bayer AG’s sustainability efforts by comparing to industry standards and government regulations for *****, resulting in significant changes in company policies to become more economically and ecologically sustainable.
• Analyzed and recommended strategy and risk for expansion and diversification of existing business. Participated in due diligence for acquisition of $80m company.
• Provided issue based technical expertise and leadership in establishing novel drug testing system worth $3m resulting in 12% increased efficacy and shorter durations for new therapeutic drug testing by designing and developing analytical models that support required project deliverables and address unforeseen issues.
• Functionally reorganized five life-science laboratories by strategically planning and benchmarking R&D spend, streamlining – operations and supply chain processes and providing technical knowledge, resulting in approximately 35% and 28% increase in capacity & productivity, respectively.
• Built and developed long-term senior level contacts and internal and external network relationships to help clients with current and future issues facing pharmaceutical and life-sciences R&D. Formulated pragmatic growth strategy for their therapeutic drug portfolio based on scenario planning for the future.
• Identified complex issues and provided tailored analysis of problems by working with client’s executives and floor teams. Presented insightful conclusions and viable recommendations based on the company’s strategy and competitive strategic analysis of existing market conditions resulting in increased profitability (average of 20%) and increased ROI for all stakeholders.
• Advised on ways of inorganic growth including M&A and licensing; participated in due diligence processes to acquire a small sized pharmaceutical enterprise for $7.5m.
• Formulated and presented cost-benefit analysis for procurement including spend analysis, supplier evaluation, strategic sourcing, outsourcing/off-shoring advice, product portfolio, pricing and market access.
• Initiated program to enhance personal experience, development and training of staff and students by implementing weekly meetings, presentations and feedback sessions at Dept. of Neurobiology and Behaviour, UC-Irvine.